Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||PAA165994/ EX65 / 1||LA / -|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: NO
Diagnostic Lab Data:
CDC 'Split Type': IEPFIZER INC2021654767
Write-up: Faint post vaccination; This is a spontaneous report from a contactable consumer(patient) via Pfizer sponsored program. A 22-years-old non pregnant female patient received first dose of BNT162B2 (COMIRNATY, Solution for injection, Lot# PAA165994/ EX6537), via an unspecified route of administration on 04Jun2021 at 10:00 into arm left as a single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 04Jun2021 at 10:30, the patient experienced faint post vaccination. Therapeutic measures were taken as a result of faint post vaccination. The outcome of the event was recovered.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166